Recreational marijuana is now legal in California. On January 1st the law went into effect with over 90 dispensaries licensed to sell weed. Greg Zeman, Associate Editor at Cannabis Now, joins Cheddar to discuss the milestone and what's next for the industry. Zeman breaks down what is believed to be the very first purchase of the now-legal substance in California. The cannabis market is expected to generate at least $1 billion a year in tax revenue for the golden state. He talks about how the state will allocate the money in terms of cannabis education, safety, and boosting other areas of the community such as fire departments. Plus, how will this impact the medical marijuana industry. Zeman predicts that market will still exist. Many cities in California still don't have a recreational license, so people will still need to rely on their medical marijuana cards to purchase the drug.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More